Cargando…

Business-as-Usual will not Deliver the COVID-19 Vaccines We Need

Governments must become active shapers of medical innovation and drive the development of critical health technologies as global health commons. The ‘race’ for COVID-19 vaccines is exposing the deficiencies of a business-as-usual medical innovation ecosystem driven by corporate interests, not health...

Descripción completa

Detalles Bibliográficos
Autor principal: Torreele, Els
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Palgrave Macmillan UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649577/
https://www.ncbi.nlm.nih.gov/pubmed/33192028
http://dx.doi.org/10.1057/s41301-020-00261-1
_version_ 1783607352441700352
author Torreele, Els
author_facet Torreele, Els
author_sort Torreele, Els
collection PubMed
description Governments must become active shapers of medical innovation and drive the development of critical health technologies as global health commons. The ‘race’ for COVID-19 vaccines is exposing the deficiencies of a business-as-usual medical innovation ecosystem driven by corporate interests, not health outcomes. Instead of bolstering collective intelligence, it relies on competition between proprietary vaccines and allows the bar on safety and efficacy to be lowered, risking people’s health and undermining their trust.
format Online
Article
Text
id pubmed-7649577
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Palgrave Macmillan UK
record_format MEDLINE/PubMed
spelling pubmed-76495772020-11-09 Business-as-Usual will not Deliver the COVID-19 Vaccines We Need Torreele, Els Development (Rome) Upfront Governments must become active shapers of medical innovation and drive the development of critical health technologies as global health commons. The ‘race’ for COVID-19 vaccines is exposing the deficiencies of a business-as-usual medical innovation ecosystem driven by corporate interests, not health outcomes. Instead of bolstering collective intelligence, it relies on competition between proprietary vaccines and allows the bar on safety and efficacy to be lowered, risking people’s health and undermining their trust. Palgrave Macmillan UK 2020-11-09 2020 /pmc/articles/PMC7649577/ /pubmed/33192028 http://dx.doi.org/10.1057/s41301-020-00261-1 Text en © Society for International Development 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Upfront
Torreele, Els
Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
title Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
title_full Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
title_fullStr Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
title_full_unstemmed Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
title_short Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
title_sort business-as-usual will not deliver the covid-19 vaccines we need
topic Upfront
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649577/
https://www.ncbi.nlm.nih.gov/pubmed/33192028
http://dx.doi.org/10.1057/s41301-020-00261-1
work_keys_str_mv AT torreeleels businessasusualwillnotdeliverthecovid19vaccinesweneed